Capstan Therapeutics
Haig Aghajanian, Ph.D., is Co-Founder and Vice President of Research at Capstan, as well as Adjunct Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. His research has focused on the etiology of cardiac disease and cell therapy for the treatment of fibrosis culminating in his recent work published in Nature and Science that served as the inception of Capstan.
This person is not in any offices
Capstan Therapeutics
2 followers
Capstan Therapeutics is advancing precision in vivo cell engineering to develop therapeutics for a broad range of disease categories with unmet or underserved clinical need.